Sentences with phrase «effect of the new technology»

The courts now have to address the effect of new technologies.

Research on the effects of these new technologies and the development of synthetic biology - specific regulations must keep pace with the technologies» development.

A side effect of the new technology is the unique appearance of the coated discs.

All we're seeing here is the net effect of new technology being used to give people something they want but couldn't previously get.

He has a longstanding interest in landscape painting along with other interests in transcendental abstraction and the effect of new technologies on painting (he is a member of LAND2 landscape research group).

Additional texts have focused on the challenges of exhibiting performance art (95) and the effects of new technologies and social media on the live arts (94).

This has long been an issue of interest to TreeHugger, because of the question about which uses less energy and resources, an e-book or a paper book (they both have a big impact), and because we often worry about the effects of new technologies.

The period saw reports from a committee advising the President of the United States on the general application of AI and a commission established by the American Bar Association looking at the effect of new technology on law which also considered AI.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

And just as the elevator's effects were amplified by the near - simultaneous introduction of other key tools and practices — from reinforced concrete to new methods of producing steel and framing buildings to modern ventilation systems — so, too, the most transformative of effects over the next decade or two are sure to be found in the confluence of new technologies and ideas.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

These risks include, in no particular order, the following: the trends toward more high - definition, on - demand and anytime, anywhere video will not continue to develop at its current pace or will expire; the possibility that our products will not generate sales that are commensurate with our expectations or that our cost of revenue or operating expenses may exceed our expectations; the mix of products and services sold in various geographies and the effect it has on gross margins; delays or decreases in capital spending in the cable, satellite, telco, broadcast and media industries; customer concentration and consolidation; the impact of general economic conditions on our sales and operations; our ability to develop new and enhanced products in a timely manner and market acceptance of our new or existing products; losses of one or more key customers; risks associated with our international operations; exchange rate fluctuations of the currencies in which we conduct business; risks associated with our CableOS ™ and VOS ™ product solutions; dependence on market acceptance of various types of broadband services, on the adoption of new broadband technologies and on broadband industry trends; inventory management; the lack of timely availability of parts or raw materials necessary to produce our products; the impact of increases in the prices of raw materials and oil; the effect of competition, on both revenue and gross margins; difficulties associated with rapid technological changes in our markets; risks associated with unpredictable sales cycles; our dependence on contract manufacturers and sole or limited source suppliers; and the effect on our business of natural disasters.

Hear from one of the most celebrated visual - effects gurus about how technology can let creativity flourish, and from the leader of ILMxLAB about how Lucasfilm is dedicating itself to new methods of storytelling and immersive entertainment.

Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.

To get the most out of the new technologies, we will need to work together to proactively mitigate the more harmful side effects that I have mentioned: the transition period and the potential effects on the distribution of income.

The hollowing out of the middle could be further accentuated by automation.8 Moreover, the polarizing effect of technology on income distribution could be heightened by a winner - takes - all effect — this comes from the market power that new technologies can often bestow on their inventors.

Actually because of tax effects, network effects, and ease of scaling / ephemeralization, technology companies in general are strongly incentivized to not actually realize profits and instead continually defer them either through incremental or new strategic investments (e.g. like Amazon).

These factors — many of which are beyond our control and the effects of which can be difficult to predict — include: credit, market, liquidity and funding, insurance, operational, regulatory compliance, strategic, reputation, legal and regulatory environment, competitive and systemic risks and other risks discussed in the risk sections of our 2017 Annual Report; including global uncertainty and volatility, elevated Canadian housing prices and household indebtedness, information technology and cyber risk, regulatory change, technological innovation and new entrants, global environmental policy and climate change, changes in consumer behavior, the end of quantitative easing, the business and economic conditions in the geographic regions in which we operate, the effects of changes in government fiscal, monetary and other policies, tax risk and transparency and environmental and social risk.

Tarkington, who saw the effects of the industrial revolution in his neck of the woods in the late nineteenth century, used the novel to talk about the rise of new technology — in this case, the automobile — and the impact it would have on an idyllic life.

The effects of technology, with this view, are cloaked in subtle epistemic shifts that happen with each new technology introduced into society.

A new study from the Family Online Safety Institute (FOSI) reveals that the large majority of parents believe technology has a positive effect on their child's future, career and life skills (78 %) and creativity (64 %).

Washington, D.C. — A new study from the Family Online Safety Institute (FOSI) reveals that the large majority of parents believe technology has a positive effect on their child's future, career and life skills (78 %) and creativity (64 %).

A new bill that is now in effect for 2017 that mandates a study of safety at grade crossings, the possibility of implementing design changes, the quality of traffic and pedestrian warning signals, and the cost to equip commuter trains with Positive Train Control technology.

Some observers quietly worry that, under Trump, a new focus on climate engineering could become part of a justification for delaying government action to curb carbon emissions, with the reasoning that geoengineering technologies could later be used to remove carbon from the atmosphere, or prevent the warming effects of solar radiation.

Even as new technology — tanks, airplanes, submarines and poison gas — changed the nature of fighting, it was the power of mass manufacturing that had the most profound effect on the conduct of war.

This study's finding — based on analysis of data from 1995 to 2014 — that the decline in under - five death was also accompanied by increases in PMI - funded malaria prevention technologies, such as insecticide treated nets and indoor residual spraying that are known to be effective malaria interventions, provides compelling and important new evidence of the likely effects of PMI funding.

New technology and research platforms are making it possible for researchers to identify those individuals and populations that will survive in the climates of the future and in the face of the myriad cascading effects of climate change.

Ms Koechlin, Professor Philippe Autier and colleagues used statistical models to work out whether current cancer death rates were due more to the effects of age, the year of birth (which takes into account exposure to cancer - causing agents such as sunshine during early life), or to the recent introduction of new medical technologies or treatments.

New molecular imaging technologies can make it easier to diagnose, monitor, and treat cancers while potentially saving patients from undergoing therapies that are likely to be ineffective and playing a role in minimizing side effects, according to experts from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania.

In addition, Rovira explains that a collateral effect, but positive for Europe, is the attractiveness of the application of new technologies in the field - robotics, precision agriculture and information technologies - for young farmers, «as the high average age of farmers is a recurring matter of concern in industrialised countries.»

«However, our new approach uses cutting - edge DNA sequencing technology to precisely measure the effects of thousands of sequences on gene activity at the same time.»

Perception researchers Edward H. Adelson of the Massachusetts Institute of Technology and J. Anthony Movshon of New York University have done some clever experiments to show that, contrary to naive intuition, this effect does not happen simply by averaging the vectors of the two stripes.

This will help in predicting the value of their magnetoelectric effect, which, in turn, will make it easier to find new and promising materials for industrial applications,» says the head of MIPT's Laboratory of physics of magnetic heterostructures and spintronics for energy - saving information technologies, Prof. Anatoly Zvezdin.

The combined effect of the three, the scientists found, is that the global energy system could experience unprecedented changes in the growth of natural gas production and significant changes to the types of energy used, but without much reduction to projected climate change if new mitigation policies are not put in place to support the deployment of renewable energy technologies.

U of T researchers have developed a new technology for creating more durable disease - fighting molecules which could lead to drugs with longer - lasting effects.

In a new study in the Journal of Sports Engineering and Technology, the mathematicians write: «We do not expect this article to have an immediate effect on the climbing community, but by providing a prescription for a mathematically ideal rope, the work may help guide the development of new ropes.»

In hopes of limiting the disastrous environmental effects of massive oil spills, materials scientists from Drexel University and Deakin University, in Australia, have teamed up to manufacture and test a new material, called a boron nitride nanosheet, that can absorb up to 33 times its weight in oils and organic solvents — a trait that could make it an important technology for quickly mitigating these costly accidents.

The ripple of a new technology throughout the economy leads to effects that are not predictable by examining each industry in isolation.

These new technologies will be «incredibly valuable» for creating sound effects for immersive environments like computer games, says Robin Shenfield, chief executive of London - based digital production company The Mill.

I also believe that many in radiation oncology embrace new technology, not simply to have the latest and greatest innovations, but rather to reduce the effect of radiation therapy on patients» quality of life.

They are the first ones to make a quantified model of the effects of the plumes, says Kent Condie at the New Mexico Institute of Mining and Technology in Socorro.

Through «heart - on - a-chip» technology — modeling a human heart on an engineered chip and measuring the effects of compound exposure using microelectrodes — Lawrence Livermore researchers hope to ensure potentially lifesaving new drugs are safe and effective while reducing the need for human and animal testing.

In fact, the FDA has recommended that newer technologies be employed as soon they become available, to reduce the possibility of very serious off - target effects of therapeutic antibodies that bind to antigens in non-target tissues.

Through «heart - on - a-chip» technology — modeling a human heart on an engineered chip and measuring the effects of compound exposure on functions of heart tissue using microelectrodes — Lawrence Livermore National Laboratory (LLNL) researchers hope to decrease the time needed for new drug trials and ensure potentially lifesaving drugs are safe and effective while reducing the need for human and animal testing.

The effects of human activity have long been cited as a primary cause of global climate change, but new research from NASA has revealed that our use of technology also appears to be having an impact not just on the planet, but on Earth's near - space environment as well.

Researchers from Brigham and Women's Hospital are leveraging these new technologies to study the effects of DISC1 mutations in cerebral organoids - «mini brains» - cultured from human stem cells.

With our proprietary technology, we are developing novel medicines designed to achieve therapeutic effects specifically at the source of disease to deliver new solutions for patients.

New genetic technologies developed over the past decade have helped researchers examine the functional effects of genetic alterations that underlie the development of cancer.

The event will focus on Hawaii's native forest birds, the deleterious effect of avian malaria, and the potential to use new genomic technologies to eliminate this problem.